Endothelial-To-Mesenchymal Transition in Pulmonary Hypertension

Circulation - United States
doi 10.1161/circulationaha.114.008750
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Loss of Family With Sequence Similarity 13, Member a Exacerbates Pulmonary Hypertension Through Accelerating Endothelial-To-Mesenchymal Transition

2019English

Endothelial-Specific Loss of IFT88 Promotes Endothelial-To-Mesenchymal Transition and Exacerbates Bleomycin-Induced Pulmonary Fibrosis

Scientific Reports
Multidisciplinary
2020English

Endothelial-Mesenchymal Transition in Atherosclerotic Lesion Calcification

Atherosclerosis
Cardiovascular MedicineCardiology
2016English

Transition of Mesenchymal Stem/Stromal Cells to Endothelial Cells

Stem Cell Research and Therapy
GeneticsCell BiologyMolecular BiologyBiochemistryMedicineMolecular Medicine
2013English

Endocardial Fibroelastosis Is Caused by Aberrant Endothelial to Mesenchymal Transition

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2015English

Valproic Acid Induces Endothelial-To-Mesenchymal Transition-Like Phenotypic Switching

Frontiers in Pharmacology
Pharmacology
2018English

Bosentan and Improved Pulmonary Endothelial Function in Pulmonary Arterial Hypertension

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2010English

Endothelial to Mesenchymal Transition in Cardiovascular Diseases: Developmental Signalling Pathways Gone Awry

Developmental Dynamics
Developmental Biology
2017English

lncRNA H19 Prevents Endothelial–mesenchymal Transition in Diabetic Retinopathy

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy